Saturday, July 11, 2026

pharma · Chronic Obstructive Pulmonary Disease

Henan University of

Henan University of is a pharma organization headquartered in CN. Primary therapeutic focus areas include Chronic Obstructive Pulmonary Disease. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Clinical program

Bufei Yishen granule

Phase 3 · small molecule · Chronic Obstructive Pulmonary Disease

Bufei Yishen granule for Chronic Obstructive Pulmonary Disease is a Phase 3 program (small_molecule) at Henan University of Traditional Chinese Medicine with 1 ClinicalTrials.gov record(s).

Internal code TCM for GOLD stage 3 or 4 COPD

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Henan University of Traditional Chinese Medicine
Phase
Phase 3
Modality
small_molecule
Indication
Chronic Obstructive Pulmonary Disease
Status
active
Trials
1

Clinical trials